Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis.
Nick J BesselinkA A A WestgeestR KlaasenM GamalaJ M van WoerkomJ TekstraM M A VerhoevenW E Van SpilF P J G LafeberA C A MarijnissenJ M Van LaarJ W G JacobsPublished in: Trials (2019)
Dutch Trial Register, NTR6388. Registered on 6 April 2017 ( NL50026.041.14 ). Protocol version 3.0, 19-01-2017.
Keyphrases
- disease activity
- rheumatoid arthritis
- study protocol
- systemic lupus erythematosus
- randomized controlled trial
- rheumatoid arthritis patients
- ankylosing spondylitis
- clinical trial
- juvenile idiopathic arthritis
- optical coherence tomography
- interstitial lung disease
- high resolution
- phase iii
- high speed
- open label
- mass spectrometry
- phase ii
- computed tomography
- combination therapy
- systemic sclerosis